The 4-7 April convening of the WHO Strategic Advisory Group of Experts on Immunization (SAGE) evaluated the evidence that has been emerging over past years that single-dose schedules provide comparable efficacy to the...
A vaccine introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus’s prevalence in teenage girls by almost two-thirds, federal researchers said. Even for...
Finding the cure to cervical cancer may be closer than we think, as a genetically engineered cervical cancer vaccine has performed well during clinical trials. The new study, published in the journal Lancet, shows that...
New research suggests that a recently developed human papillomavirus (HPV) vaccine can potentially prevent 80 percent of cervical cancers if it is administered before the child is 11 or 12 years old. HPV is a common...
University of Alabama at Birmingham (UAB) Division of Gynecologic Oncology director Warner Huh, M.D. says a new human papillomavirus (HPV) vaccine has the potential to reduce cervical cancer rates, while reducing the...
Encouraging results have recently emerged regarding a new vaccine which suggests that with continued development the elimination of cervical cancer could be on the cards. The new vaccine targets the human papillomavirus...